Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03531645
Title Fulvestrant Plus Palbociclib in Women With Advanced Low Grade Serous Carcinoma
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

peritoneal carcinoma

fallopian tube carcinoma

ovarian serous carcinoma

Therapies

Fulvestrant + Palbociclib

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.